lithium carbonate: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Alembic Ltd	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	079159	ANDA	Alembic Pharmaceuticals Limited	46708-303-30	30 CAPSULE in 1 BOTTLE (46708-303-30)	2016-12-27
Alembic Ltd	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	079159	ANDA	Alembic Pharmaceuticals Limited	46708-303-31	100 CAPSULE in 1 BOTTLE (46708-303-31)	2016-12-27
Alembic Ltd	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	079159	ANDA	Alembic Pharmaceuticals Limited	46708-303-71	500 CAPSULE in 1 BOTTLE (46708-303-71)	2016-12-27
Alembic Ltd	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	079159	ANDA	Alembic Pharmaceuticals Limited	46708-303-91	1000 CAPSULE in 1 BOTTLE (46708-303-91)	2016-12-27
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 28, 2025

Introduction

Lithium carbonate, a key compound in psychiatric medication, particularly for bipolar disorder, has become an integral component of global pharmaceutical manufacturing. The demand for lithium carbonate has surged in recent years, driven by increasing mental health awareness and expanding treatment guidelines. To meet this growing need, pharmaceutical companies rely on a robust supply chain comprising various raw material suppliers, chemical producers, and intermediaries. This article provides a comprehensive analysis of the primary suppliers of lithium carbonate used in pharmaceutical applications, highlighting their geographical distribution, production capacity, quality standards, and market dynamics.

Global Supply Landscape of Lithium Carbonate

The lithium carbonate market has experienced exponential growth over the past decade, making it a critical focus for pharmaceutical manufacturers seeking reliable supply sources. The supply chain is complex, involving mining, mineral processing, chemical refining, and quality control, with suppliers operating across major lithium-producing regions.

The key regions involved in lithium carbonate production include South America (notably Chile and Argentina), Australia, China, and smaller contributors from African countries. While these regions dominate lithium extraction, the pharmaceutical-grade lithium carbonate is supplied by specialized chemical producers that adhere strictly to pharmaceutical standards, such as USP or European Pharmacopoeia requirements.

Major Suppliers of Pharmaceutical-Grade Lithium Carbonate

1. SQM (Sociedad Química y Minera de Chile)

Overview:
SQM, headquartered in Chile, is one of the world’s largest producers of lithium, offering high-purity lithium carbonate suitable for pharmaceutical use. Its vertically integrated supply chain ensures stringent control over quality and purity standards.

Production Capabilities:
SQM’s lithium production spans the Atacama Desert, harnessing lithium-rich brine deposits. The company’s capacity exceeds 20,000 tons annually, with a significant proportion allocated for high-purity pharmaceutical-grade lithium carbonate.

Quality Standards:
SQM’s lithium carbonate products are compliant with pharmaceutical specifications, including USP and EP standards, ensuring suitability for medical applications. Their rigorous quality management systems support consistent chemical purity and low impurity levels.

Market Position:
SQM’s strategic location, extensive resource base, and commitment to quality have made it a preferred supplier for multinational pharmaceutical companies.

2. Albemarle Corporation

Overview:
Based in the United States, Albemarle is a leading specialty chemicals company with a dominant position in lithium production. Its Chilean lithium operations, notably the Silver Peak and Atacama facilities, provide substantial volumes of pharmaceutical-grade lithium carbonate.

Production Capabilities:
Albemarle’s comprehensive lithium extraction and chemical processing facilities deliver over 40,000 tons of lithium compounds annually. Its focus on high-purity lithium carbonate aligns with pharmaceutical demands.

Quality Standards:
Albemarle maintains strict quality control protocols, supplying pharmaceutical-grade lithium carbonate that meets or exceeds USP, EP, and other regulatory standards.

Market Position:
Albemarle’s extensive experience, reliable supply chain, and commitment to quality have cemented its leadership status in lithium markets globally.

3. Ganfeng Lithium

Overview:
Chinese company Ganfeng Lithium is a prominent player providing integrated lithium supply solutions, including lithium carbonate suitable for pharmaceuticals.

Production Capabilities:
Ganfeng’s diversified lithium projects span China, Australia, and Argentina, capable of producing over 30,000 tons annually, with a significant portion dedicated to pharmaceutical-grade products.

Quality Standards:
Ganfeng emphasizes high-purity lithium carbonate and has obtained certifications aligning with global pharmaceutical quality specifications, facilitating exports to Western markets.

Market Position:
Ganfeng’s vertical integration and focus on high-quality output position it as a key supplier in the growing pharmaceutical and battery markets.

4. Tianqi Lithium

Overview:
Tianqi Lithium, headquartered in China, operates some of the largest lithium extraction facilities globally, providing lithium carbonate that meets pharmaceutical standards.

Production Capabilities:
Their operations, primarily in Australia’s Greenbushes mine, produce over 50,000 tons of lithium hydroxide and carbonate annually, with a focus on premium-quality supplies.

Quality Standards:
Tianqi emphasizes purity and chemical stability, ensuring products meet international pharmaceutical requirements.

Market Position:
As part of the Tianqi Group’s vertically integrated lithium ecosystem, they enjoy a competitive edge in supply consistency and quality assurance.

5. Mineral Resources Limited / Pilbara Minerals

Overview:
Australian resource companies, including Mineral Resources and Pilbara Minerals, are expanding their production capacities to supply high-grade lithium carbonate suitable for pharmaceutical applications.

Production Capabilities:
Pilbara Minerals’ Pilgangoora project and Mineral Resources’ Mount Marion operation collectively produce significant lithium hydroxide and carbonate volumes, with ongoing ramp-ups aiming at pharmaceutical-grade quality.

Quality Standards:
Both companies aim to meet international standards, and their lithium carbonate products are increasingly certified for pharmaceutical use, especially in the Asia-Pacific region.

Emerging and Niche Suppliers

While the aforementioned giants dominate the global lithium carbonate supply for pharmaceutical purposes, several smaller or emerging players contribute niche supplies or are poised to expand:

Orocobre (now Galaxy Resources): An Australia-based producer expanding into high-purity lithium carbonate markets.
AT lithium: Emerging Chinese manufacturer focusing on pharmaceutical-grade lithium compounds.
Check suppliers in African countries: Particularly Zimbabwe and Zimbabwean lithium projects, which are in early development stages but could become relevant suppliers in the future.

Quality and Regulatory Considerations

Pharmaceutical-grade lithium carbonate demands stringent quality standards. Each supplier must comply with internationally recognized pharmacopoeias, including:

United States Pharmacopeia (USP)
European Pharmacopoeia (EP)
Japanese Pharmacopoeia (JP)

This entails comprehensive testing for impurities, such as heavy metals, residual solvents, and other contaminants, ensuring patient safety and regulatory compliance.

Suppliers often obtain GMP (Good Manufacturing Practice) certifications and undergo audits by pharmaceutical clients or regulatory agencies, emphasizing the importance of quality assurance in their production processes.

Supply Chain Challenges and Opportunities

Supply chain disruptions, geopolitical factors, and environmental regulations influence lithium carbonate sourcing. The concentration of supply among few large producers can lead to bottlenecks, price volatility, and strategic vulnerabilities for pharmaceutical companies.

Advancements in extraction technologies, recycling initiatives, and new mining projects aim to diversify and stabilize the supply chain. Notably, efforts toward sustainable extraction and ethical sourcing are increasingly prioritized, aligning with healthcare providers’ growing focus on environmental, social, and governance (ESG) criteria.

Key Factors for Selecting Lithium Carbonate Suppliers

Purity and Certification: Ensure products meet pharmaceutical specifications (USP, EP, JP).
Production Capacity & Reliability: Assess capacity relative to market needs and supplier track record.
Supply Chain Stability: Consider geopolitical stability, logistics, and contractual terms.
Environmental & Ethical Standards: Favor suppliers adhering to sustainable and ethical mining and processing practices.
Cost & Lead Time: Balance quality requirements with economic considerations and delivery timelines.

Key Takeaways

Globally, leading suppliers of pharmaceutical-grade lithium carbonate include SQM, Albemarle, Ganfeng Lithium, Tianqi Lithium, and emerging Australian companies such as Mineral Resources and Pilbara Minerals.
The supply chain is concentrated among a handful of large producers, underscoring the importance of diversification strategies for pharmaceutical companies.
Strict quality standards, certifications, and regulatory compliance are paramount, with suppliers needing to demonstrate GMP adherence and pharmacopoeial certifications.
Market dynamics, including geopolitical tensions, environmental concerns, and technological advances, influence future supply stability and availability.
Sustainability and ethical sourcing are increasingly integral to procurement decisions, impacting supplier selection.

FAQs

1. What constitutes pharmaceutical-grade lithium carbonate?
Pharmaceutical-grade lithium carbonate meets strict specifications regarding chemical purity, purity of lithium content, and minimal impurities such as heavy metals or residual solvents, conforming to pharmacopoeial standards like USP or EP.

2. Which countries dominate the lithium carbonate supply for pharmaceuticals?
Chile and Australia dominate lithium extraction, with China and the United States hosting major chemical processing facilities capable of producing pharmaceutical-grade lithium carbonate.

3. Are there opportunities for new suppliers in this market?
Yes. As demand grows, particularly with advancements in sustainable extraction, new entrants with innovative, environmentally friendly technologies and certifications may emerge as reliable suppliers.

4. How do supply chain disruptions affect pharmaceutical manufacturing?
Disruptions can lead to shortages, affecting drug availability and margins. This underscores the importance of diversified sourcing, strategic inventories, and supplier qualification.

5. What environmental considerations are linked to lithium carbonate sourcing?
Extraction impacts water resources, ecosystems, and local communities. Pharmaceutical companies increasingly scrutinize supplier adherence to ESG standards, favoring sustainable and ethically sourced lithium.

References

[1] Bloomberg Industry Reports, "Global Lithium Market Overview," 2022.
[2] US Pharmacopeia, "Lithium Carbonate Monograph," 2021.
[3] Albemarle Corporation Annual Report, 2022.
[4] SQM Sustainability Report, 2022.
[5] Ganfeng Lithium Regulatory & Quality Data, 2022.

Suppliers and packagers for generic pharmaceutical drug: lithium carbonate